Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec's InCog(TM), an Innovative Lipid Composition for Cognitive Functioning, Approved as Novel Food in Europe

MIGDAL HA'EMEQ, Israel, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
November 11, 2015 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Third Quarter 2015 Results

Earns non-GAAP $0.08 and GAAP $0.07 per Diluted Share and Generates $4.7 Million in Operating Cash Flow VAYA Pharma Generates Record Net Revenues of $2.2 Million MIGDAL HA'EMEQ, Israel, Nov. 11,...
November 10, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec to Host a VAYA Pharma Analyst and Investor Day in New York City on November 19, 2015

MIGDAL HA'EMEQ, Israel, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid-based nutritional ingredients and medical...
November 09, 2015 09:00 ET | Source: Enzymotec Ltd.

Retrospective Analysis of the Effects of Enzymotec's Vayarin(R) Showed Significant Improvement of Emotional Status and Sleep Quality in ADHD Patients With Sleep Disturbances

MIGDAL HA'EMEQ, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enyzmotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based...
October 28, 2015 16:05 ET | Source: Enzymotec Ltd.

Enzymotec to Report Third Quarter 2015 Financial Results

MIGDAL HA'EMEQ, Israel, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
October 28, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Granted a New US Patent for Vayacog(R) in Pre-Dementia

MIGDAL HA'EMEQ, Israel, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
August 19, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Granted U.S. Patent for INFAT(R) to Promote Intestinal Development and Maturation

MIGDAL HA'EMEQ, Israel, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
August 12, 2015 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Second Quarter 2015 Results

Revenues and Adjusted EBITDA Increased for Fourth Consecutive Quarter Q2 Net Revenues Increased 49.5% Year-Over-Year; Q2 Net Income of $0.10 Per Diluted Share MIGDAL HA'EMEQ, Israel, Aug. 12,...
July 30, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces the Appointment of Tamar Howson to Its Board of Directors

MIGDAL HA'EMEQ, Israel, July 30, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced...
July 29, 2015 08:30 ET | Source: Enzymotec Ltd.

Enzymotec to Report Second Quarter 2015 Financial Results

MIGDAL HA'EMEQ, Israel, July 29, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...